CKDkb: a knowledge base and platform for drug development against non-alcoholic fatty liver disease

Structure:

CMap ID:	C02281
Pert ID:	BRD-A86665761
Compound Name:	gabapentin-enacarbil
Targets:	CACNA1A\|CACNA1B\|CACNA1C\|CACNA1D\|CACNA1E\|CACNA1F\|CACNA1G\|CACNA1H\|CACNA1I\|CACNA1S\|CACNA2D1\|CACNA2D2\|CACNA2D3\|CACNA2D4\|CACNB1\|CACNB2\|CACNB3\|CACNB4\|CACNG1\|CACNG2\|CACNG3\|CACNG4\|CACNG5\|CACNG6\|CACNG7\|CACNG8
MoA:	adrenergic receptor agonist
SMILES:	CC(C)C(=O)OC(C)OC(=O)NCC1(CC(O)=O)CCCCC1
InchiKey:
Compound Aliases:

The GSE89632 and GSE126848 datasets are hepatic gene expression profiles of nonalcoholic fatty liver disease (NAFLD).
Score ID	Pert ID	Cell Line	Pert Dose	Pert Time	Raw Score (GSE126848)	Normalized Score (GSE126848)	fdr_q_nlog10 (GSE126848)	Raw Score (GSE135251)	Normalized Score (GSE135251)	fdr_q_nlog10 (GSE135251)

Summary